American Association for the Advancement of Science, Science Translational Medicine, 234(6), 2014
DOI: 10.1126/scitranslmed.3008140
Full text: Unavailable
Human neutralizing monoclonal antibody could serve as a therapeutic intervention against MERS-CoV infection.